ILMN — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

4.87

Margin Of Safety %

-3

Put/Call OI Ratio

0.47

EPS Next Q Diff

-0.11

EPS Last/This Y

-0.35

EPS This/Next Y

0.72

Price

117.62

Target Price

135.56

Analyst Recom

2.35

Performance Q

-13.04

Upside

2.1%

Beta

1.49

Ticker: ILMN

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	ILMN	134.49	0.52	0.16	36785
2026-03-02	ILMN	132.98	0.53	0.13	36849
2026-03-03	ILMN	129.67	0.53	0.76	36949
2026-03-04	ILMN	129.03	0.54	0.05	37162
2026-03-05	ILMN	128.21	0.55	2.02	36908
2026-03-06	ILMN	124.66	0.52	0.22	35704
2026-03-09	ILMN	124.27	0.53	0.67	35523
2026-03-10	ILMN	122.05	0.53	6.08	35339
2026-03-11	ILMN	121.49	0.53	5.54	35527
2026-03-12	ILMN	115.54	0.50	0.30	34665
2026-03-13	ILMN	115.56	0.50	0.31	34665
2026-03-17	ILMN	120.89	0.52	0.15	36042
2026-03-18	ILMN	122.92	0.52	0.21	36091
2026-03-19	ILMN	126.54	0.52	1.51	36123
2026-03-20	ILMN	124.34	0.52	0.87	36153
2026-03-23	ILMN	123.78	0.48	0.92	16137
2026-03-24	ILMN	126.03	0.48	0.28	16297
2026-03-25	ILMN	126.31	0.47	0.41	16459
2026-03-26	ILMN	124.44	0.47	0.39	16563
2026-03-27	ILMN	117.61	0.47	2.29	16594
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	ILMN	134.49	9.2	-133.3	5.13
2026-03-02	ILMN	132.92	9.2	-151.8	5.13
2026-03-03	ILMN	129.57	9.2	-165.4	5.13
2026-03-04	ILMN	129.02	9.2	-144.5	5.13
2026-03-05	ILMN	128.22	9.2	-146.2	5.13
2026-03-06	ILMN	124.66	9.2	-168.1	5.13
2026-03-09	ILMN	124.27	9.2	-143.1	5.13
2026-03-10	ILMN	122.40	9.2	-155.4	5.13
2026-03-11	ILMN	121.52	9.2	-147.1	5.13
2026-03-12	ILMN	115.54	9.2	-189.3	5.13
2026-03-13	ILMN	118.89	9.2	-111.7	5.13
2026-03-17	ILMN	120.86	9.2	-127.1	5.12
2026-03-18	ILMN	122.94	9.2	-123.0	5.12
2026-03-19	ILMN	126.54	9.2	-145.6	5.12
2026-03-20	ILMN	124.33	9.2	-191.1	5.12
2026-03-23	ILMN	123.78	9.2	-178.1	5.12
2026-03-24	ILMN	126.03	9.2	-156.4	5.12
2026-03-25	ILMN	126.19	9.2	-172.2	5.12
2026-03-26	ILMN	124.43	9.2	-187.5	5.12
2026-03-27	ILMN	117.62	9.2	-226.6	5.12
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	ILMN	-0.09	-3.63	5.33
2026-03-02	ILMN	-0.09	0.87	5.33
2026-03-03	ILMN	-0.09	0.87	5.33
2026-03-04	ILMN	-0.09	0.87	5.33
2026-03-05	ILMN	-0.09	0.87	5.33
2026-03-06	ILMN	-0.09	0.87	5.33
2026-03-09	ILMN	-0.09	0.79	5.33
2026-03-10	ILMN	-0.09	0.79	5.33
2026-03-11	ILMN	-0.09	0.79	4.82
2026-03-12	ILMN	-0.09	0.79	4.82
2026-03-13	ILMN	-0.09	0.79	4.82
2026-03-17	ILMN	-0.09	0.84	4.82
2026-03-18	ILMN	-0.09	0.84	4.82
2026-03-19	ILMN	-0.09	0.84	4.82
2026-03-20	ILMN	-0.09	0.84	4.82
2026-03-23	ILMN	-0.09	0.78	4.82
2026-03-24	ILMN	-0.09	0.78	4.82
2026-03-25	ILMN	-0.09	0.78	4.87
2026-03-26	ILMN	-0.09	0.78	4.87
2026-03-27	ILMN	-0.09	0.78	4.87
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.35

Avg. EPS Est. Current Quarter

1.06

Avg. EPS Est. Next Quarter

1.24

Insider Transactions

-0.09

Institutional Transactions

0.78

Beta

1.49

Average Sales Estimate Current Quarter

1073

Average Sales Estimate Next Quarter

1105

Fair Value

114.28

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-86.2

Target Price

135.56

P/E

21.54

Forward P/E

20.16

PEG

1.79

P/S

4.14

P/B

6.61

P/Free Cash Flow

19.33

EPS

5.46

Average EPS Est. Cur. Y

5.12

EPS Next Y. (Est.)

5.84

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

19.58

Relative Volume

0.6

Return on Equity vs Sector %

3.9

Return on Equity vs Industry %

20.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

-226.6

◆ ILMN Healthcare

$117.67

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

13/25

Volume

9/15

Valuation

13/20

TP/AR

3/10

Options

6/10

RSI

39.6

Range 1M

13.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

14/30

Estimates

6/20

Inst/Vol

4/15

Options

6/10

EPS Yr

EPS NY

13.8%

52W%

56.4%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟡 HOLD +6.8% upside

Quality

27/30

Valuation

7/30

Growth

12/25

Stability

7/10

LT Trend

1/5

Upside

+6.8%

Quality

MoS

-3%

Illumina, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 8600

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

ILMN

Latest News

—

Caricamento notizie per ILMN…

stock quote shares ILMN – Illumina, Inc. Stock Price stock today

news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ILMN – Illumina, Inc. yahoo finance google finance

stock history ILMN – Illumina, Inc. invest stock market

stock prices ILMN premarket after hours

ticker ILMN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ILMN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y